P2Y12 receptor blockade augments glycoprotein IIb-IIIa antagonist inhibition of platelet activation, aggregation, and procoagulant activity.

J Am Heart Assoc · 2013 · PMC3698756 · PMID 23676293

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

By 2‐factor RM‐ANOVA, R‐138727, GPIIb‐IIIa antagonists, and the interaction between R‐138727 and GPIIb‐IIIa antagonists were highly significant for the collagen plus ADP–stimulated percentage of monocyte–platelet aggregates and the platelet fluorescence in monocyte–platelet aggregates (Table).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.